Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Progress in hepatitis B: a 30-year journey through three continents.

Literature DB >> 24619499

Progress in hepatitis B: a 30-year journey through three continents.

Anna Suk-Fong Lok¹.

Abstract

Entities: Chemical Disease Gene Mutation Species

Mesh：

Substances：
Hepatitis B Vaccines

Year: 2014 PMID： 24619499 PMCID： PMC4077917 DOI： 10.1002/hep.27120

Source DB: PubMed Journal: Hepatology ISSN： 0270-9139 Impact factor: 17.425

× No keyword cloud information.

27 in total

1. Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis.

Authors: H B Greenberg; R B Pollard; L I Lutwick; P B Gregory; W S Robinson; T C Merigan
Journal: N Engl J Med Date: 1976-09-02 Impact factor: 91.245

2. Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication.

Authors: A S Lok; I V Weller; P Karayiannis; D Brown; M J Fowler; J Monjardino; H C Thomas; S Sherlock
Journal: Liver Date: 1984-02

3. Lamivudine for patients with chronic hepatitis B and advanced liver disease.

Authors: Yun-Fan Liaw; Joseph J Y Sung; Wan Cheng Chow; Geoffrey Farrell; Cha-Ze Lee; Hon Yuen; Tawesak Tanwandee; Qi-Min Tao; Kelly Shue; Oliver N Keene; Jonathan S Dixon; D Fraser Gray; Jan Sabbat
Journal: N Engl J Med Date: 2004-10-07 Impact factor: 91.245

4. Placebo-controlled trial of recombinant alpha 2-interferon in Chinese HBsAg-carrier children.

Authors: C L Lai; A S Lok; H J Lin; P C Wu; E K Yeoh; C Y Yeung
Journal: Lancet Date: 1987-10-17 Impact factor: 79.321

5. Contribution of low level HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection.

Authors: A S Lok; S J Hadziyannis; I V Weller; M G Karvountzis; J Monjardino; P Karayiannis; L Montano; H C Thomas
Journal: Gut Date: 1984-11 Impact factor: 23.059

6. Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection.

Authors: C I Smith; L W Kitchen; G H Scullard; W S Robinson; P B Gregory; T C Merigan
Journal: JAMA Date: 1982-04-23 Impact factor: 56.272

7. Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis.

Authors: K C Lam; C L Lai; C Trepo; P C Wu
Journal: N Engl J Med Date: 1981-02-12 Impact factor: 91.245

8. Adenine arabinoside 5'-monophosphate treatment of chronic type B hepatitis.

Authors: J H Hoofnagle; G Y Minuk; G M Dusheiko; D F Schafer; R Johnson; S Straus; E A Jones; J L Gerin; K Ishak
Journal: Hepatology Date: 1982 Nov-Dec Impact factor: 17.425

9. A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.

Authors: A S Lok; D M Novick; P Karayiannis; A A Dunk; S Sherlock; H C Thomas
Journal: Hepatology Date: 1985 Nov-Dec Impact factor: 17.425

10. Long-term follow-up in a randomised controlled trial of recombinant alpha 2-interferon in Chinese patients with chronic hepatitis B infection.

Authors: A S Lok; C L Lai; P C Wu; E K Leung
Journal: Lancet Date: 1988-08-06 Impact factor: 79.321

3 in total